about
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitorsARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eneda Toska
@en
Eneda Toska
@nl
type
label
Eneda Toska
@en
Eneda Toska
@nl
prefLabel
Eneda Toska
@en
Eneda Toska
@nl
P31
P496
0000-0002-8974-9792